Artificial Intelligence (AI) is a computer performing tasks commonly associated with human intelligence. Integration of AI technology in cancer care could improve the accuracy and speed of diagnosis, aid clinical decision-making, and lead to better health outcomes. The global artificial intelligence (ai) in cancer market market is projected to rise by USD 3,846 million by 2028, according to a new report by Gen Consulting Company. It is anticipated to expand at a CAGR of 33.4 percent during the forecast period.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global artificial intelligence (ai) in cancer market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the artificial intelligence (ai) in cancer industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, application, and region. The global market for artificial intelligence (ai) in cancer can be segmented by type: machine learning (ML), natural language processing (NLP). Artificial intelligence (ai) in cancer market is further segmented by application: diagnosis, prognosis, research, therapy, others. The diagnosis segment was the largest contributor to the global artificial intelligence (ai) in cancer market in 2021. Based on region, the artificial intelligence (ai) in cancer market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By type:
– machine learning (ML)
– natural language processing (NLP)

By application:
– diagnosis
– prognosis
– research
– therapy
– others

By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)

The report explores the recent developments and profiles of key vendors in the Global Artificial Intelligence (AI) in Cancer Market, including Aidence B.V., Butterfly Network, Inc., Day Zero Diagnostics (DZD), Enlitic LLC, GE Healthcare, Ibex Medical Analytics Ltd., Intel Corporation, International Business Machines Corporation (IBM), Microsoft Corporation, Nano-X Imaging Ltd., Nvidia Corporation, Optellum Ltd, Prognos Health Inc., Siemens Healthineers AG, Xilinx, Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global artificial intelligence (ai) in cancer market.
– To classify and forecast the global artificial intelligence (ai) in cancer market based on type, application, region.
– To identify drivers and challenges for the global artificial intelligence (ai) in cancer market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global artificial intelligence (ai) in cancer market.
– To identify and analyze the profile of leading players operating in the global artificial intelligence (ai) in cancer market.

Why Choose This Report
– Gain a reliable outlook of the global artificial intelligence (ai) in cancer market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.